Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedNew quick links 'Check who can join' and 'Find Contact Information' appear on the record history page, facilitating eligibility checks and contact access. The revision note now shows Revision: v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.5%

- Check9 days agoChange DetectedThe version history now shows a new release entry for v3.5.5, replacing the previous v3.5.4. This reflects a backend/UI update without changes to the study details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Record History now includes a new Revision: v3.5.4 entry as part of the version history, and the previous Revision: v3.5.3 entry has been removed from the list. This reflects a minor site release update rather than any change to trial data or descriptions.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s developer/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a study record change.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.SummaryDifference0.1%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.